PEPG
PepGen Inc.
Latest Form 4:Sale$2KbyKasraian Kasra (Chief Technical Officer) · filed May 26, 2026
PepGen Inc. (PEPG) has 12 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: May 26, 2026.
- Industry:Biotechnology
- CEO:James McArthur
- Employees:56
- HQ:Boston, MA, US
- IPO:2022-05-06
Insider Buying
$30.6M
reported purchases (SEC code P)
Insider Selling
$59K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$217.5M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Kasraian KasraFirst filing | Chief Technical Officer | Sale | 1,233 | $2K | May 26 | SEC ↗ |
Donnelly NoelFirst filing | Chief Financial Officer | Sale | 2,084 | $13K | Mar 6 | SEC ↗ |
STRECK PAULFirst filing | EVP, Head of R&D | Sale | 1,879 | $12K | Mar 6 | SEC ↗ |
McArthur James GFirst filing | President and CEO | Sale | 5,275 | $33K | Mar 6 | SEC ↗ |
Oxford Science Enterprises plcFirst filing | Former 10% Owner | Purchase | 200,000 | $640K | Oct 1 | SEC ↗ |
| Director, 10% Owner | Purchase | 9,375,000 | $30.0M | Sep 30 | SEC ↗ |
Related companies
PepGen Inc. is in the Healthcare sector.